A French biotech company just got a two-year break from paying back millions in loans, giving it more cash to push forward on cutting-edge research. The firm, known for developing treatments targeting tough diseases, reached a deal with lenders to delay loan payments totaling around €17. 8 million.
Vanguard, a major player in the investment world, made a big splash recently by slashing fees for almost a hundred of its funds, including some popular exchange-traded funds (ETFs). This move is significant because it affects 168 different share classes, with an average reduction of 20%. The t
Sue Bird, a basketball legend with a stellar career, is making headlines in the business world. She's not just investing in businesses, but in people she trusts. Her first big bet was on a friend's restaurant venture, which paid off big time. In just a year or two, she recouped her initial investmen
